Penumbra Inc
(STU:0P8)
€
212.2
2.5 (1.19%)
Market Cap: 8.20 Bil
Enterprise Value: 8.14 Bil
PE Ratio: 266.87
PB Ratio: 7.97
GF Score: 87/100 
Penumbra Inc at Wells Fargo Healthcare Conference Transcript
Sep 07, 2022 / 01:45PM GMT
Release Date Price:
€165
(-1.20%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Good morning. I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo, and it is my pleasure to introduce Penumbra at our 2022 Healthcare Conference. With us, of course, we have Adam Elsesser, Chairman, President and CEO. I think you're also a Founder.
Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO
Kind of.
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
Yes. And so in terms of format, it's fireside chat. If anybody has a question, they want to ask, just raise your hand, and we'll call on you.
So Adam, thanks so much for being here.
Adam Elsesser;Lawrence H. Biegelsen
Penumbra, Inc. - Co-Founder, Chairman, President & CEO;Wells Fargo Securities, LLC, Research
Yes. Of course. Happy to be here, thank you.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers